Cargando…
Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy
Although there is a strong association between osteoporosis and skeletal muscle atrophy/dysfunction, the functional relevance of a particular biological pathway that regulates synchronously bone and skeletal muscle physiopathology is still elusive. Receptor-activator of nuclear factor κB (RANK), its...
Autores principales: | Dufresne, Sébastien S., Boulanger-Piette, Antoine, Bossé, Sabrina, Argaw, Anteneh, Hamoudi, Dounia, Marcadet, Laetitia, Gamu, Daniel, Fajardo, Val A., Yagita, Hideo, Penninger, Josef M., Russell Tupling, A., Frenette, Jérôme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922009/ https://www.ncbi.nlm.nih.gov/pubmed/29699580 http://dx.doi.org/10.1186/s40478-018-0533-1 |
Ejemplares similares
-
The Roles of RANK/RANKL/OPG in Cardiac, Skeletal, and Smooth Muscles in Health and Disease
por: Marcadet, Laetitia, et al.
Publicado: (2022) -
Testing the efficacy of a human full-length OPG-Fc analog in a severe model of cardiotoxin-induced skeletal muscle injury and repair
por: Bouredji, Zineb, et al.
Publicado: (2021) -
Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice
por: Boulanger Piette, Antoine, et al.
Publicado: (2018) -
RANKL Inhibition Reduces Cardiac Hypertrophy in mdx Mice and Possibly in Children with Duchenne Muscular Dystrophy
por: Marcadet, Laetitia, et al.
Publicado: (2023) -
Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
por: Ming, Jie, et al.
Publicado: (2020)